SREBF1 and Insulin resistance: This mechanism might place SREBP-1a as a gene regulatory point of convergence for inflammation, insulin resistance, obesity and intracellular lipid accumulation, since hormones, cytokines, drugs, and free fatty acids are able to activate SREBPs via MAPK cascades [18].